Axsome Therapeutics Resolves Generic Patent Litigation With Teva …
1 day ago · On Monday, Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The settlement resolves all patent litigation related to Axsome’s ...
Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva
Per the settlement terms, Axsome will grant Teva a license to sell a generic version of Auvelity in the United States, subject to approval and other customary conditions, on or after Sept. 30, 2038.
Axsome secures top drug’s future with Teva patent settlement
2 days ago · Dive Brief: Axsome Therapeutics gained more than $1 billion in market value Monday, after the brain drug developer disclosed a patent settlement with Teva Pharmaceuticals that will keep a generic copy of Axsome’s top drug at bay in the U.S. until at least 2038.; Axsome had sued Teva for patent infringement when the generic drugmaker filed for approval of a knock-off version of Auvelity, a ...
Teva agrees with Axsome to keep generic off market until 2038
1 day ago · The FDA approved Auvelity in August of 2022 and just six months later, according to a securities filing, Teva notified Axsome that it was applying for FDA approval of its copycat. A month later ...
Axsome Therapeutics Announces Settlement Agreement …
1 day ago · Under the terms of the settlement agreement, Axsome will grant Teva a license to sell its generic version of AUVELITY beginning on or after March 31, 2039, if pediatric exclusivity is granted for ...
Axsome Therapeutics Resolves Generic Patent Litigation With Teva …
2 days ago · Axsome grants Teva a license to sell generic Auvelity starting in 2038 or 2039, resolving all ongoing patent litigation. Axsome's Q4 and full-year 2024 Auvelity sales are expected at $92.6M and ...
Axsome announces settlement agreement resolving AUVELITY …
1 day ago · Axsome Therapeutics announced that it has entered into a settlement agreement with Teva Pharmaceuticals (TEVA) resolving all patent litigation related to Axsome’s AUVELITY product.The litigation ...
Axsome Therapeutics Settles Patent Litigation With Teva
1 day ago · (RTTNews) - Axsome Therapeutics, Inc. (AXSM) announced on Monday that it has reached a settlement agreement with Teva Pharmaceuticals (TEVA), resolving all ongoing patent litigation related to its ...
Axsome Therapeutics Reaches Settlement With Teva On …
1 day ago · Under the terms of the settlement agreement, Axsome will grant Teva a license to sell its generic version of AUVELITY beginning on or after March 31, 2039, if pediatric exclusivity is granted for ...
Axsome Settling Teva Patent Litigation Is Another Positive …
5 hours ago · Axsome Therapeutics, Inc.'s stock has surged over 30% since my last “Hold” rating, driven by key catalysts like the litigation settlement with Teva Pharmaceuticals, announced today.
- Some results have been removed